David Krempa

Chief Business Officer, Eton Pharmaceuticals, Inc.

Companies

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Aug 24, 2026Sold 25,000 shares at $65.07 of Eton Pharmaceuticals, Inc.²
Aug 24, 2026Exercised options 25,000 shares at $7.31 of Eton Pharmaceuticals, Inc.²
Jul 12, 2026Exercised options 10,000 shares of Eton Pharmaceuticals, Inc.³
May 27, 2026Sold 19,679 shares at $31.47 of Eton Pharmaceuticals, Inc.⁴
May 27, 2026Exercised options 7,203 shares at $3.58 of Eton Pharmaceuticals, Inc.⁴
May 27, 2026Exercised options 12,476 shares at $1.37 of Eton Pharmaceuticals, Inc.⁴
May 26, 2026Sold 37,524 shares at $31.49 of Eton Pharmaceuticals, Inc.⁴
May 26, 2026Exercised options 12,524 shares at $1.37 of Eton Pharmaceuticals, Inc.⁴
May 26, 2026Exercised options 25,000 shares at $1.38 of Eton Pharmaceuticals, Inc.⁴
May 22, 2026Sold 519 shares at $35.00 of Eton Pharmaceuticals, Inc.⁴
May 22, 2026Sold 9,315 shares at $33.88 of Eton Pharmaceuticals, Inc.⁴
May 22, 2026Sold 32,963 shares at $33.22 of Eton Pharmaceuticals, Inc.⁴
May 22, 2026Exercised options 30,591 shares at $3.58 of Eton Pharmaceuticals, Inc.⁴
Jan 14, 2026Shares withheld for tax 1,942 shares at $15.62 of Eton Pharmaceuticals, Inc.⁵
Dec 12, 2025Shares withheld for tax 6,264 shares at $17.00 of Eton Pharmaceuticals, Inc.⁶
Jun 16, 2025Sold 10,223 shares at $14.73 of Eton Pharmaceuticals, Inc.⁷
Jun 13, 2025Sold 6,800 shares at $14.77 of Eton Pharmaceuticals, Inc.⁷
Jun 12, 2025Sold 16,977 shares at $14.92 of Eton Pharmaceuticals, Inc.⁷

The numbers on this page point here. Each one links to the record it came from.